SEARCH

SEARCH BY CITATION

References

  • 1
    Cunninghan FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams Obstetrics, 23rd edn. Now York: MC Graw Hill Medical, 2010; 706711.
  • 2
    Jacquemyn Y, Zemtsova O. Risk factors and prediction of pre-eclampsia. Acta Clin Belg 2010; 65: 112.
  • 3
    Taylor RN, Davidge ST, Roberts JM. Endothelial cell dysfunction and oxidative stress. In: Lindheimer MD , Cunningham FG , Roberts JM (eds). Chesley's Hypertensive Disorders in Pregnancy, 3rd edn. Amsterdam: Elsevier, 2009; 145170.
  • 4
    Gervasi MT, Chaiworapongsa T, Pacora P et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in pre-eclampsia. Am J Obstet Gynecol 2001; 185: 722727.
  • 5
    Faas MM, Schuiling GA, Linton EA, Sargent IL, Redman CW. Activation of peripheral leukocytes in rat pregnancy and experimental pre-eclampsia. Am J Obstet Gynecol 2000; 182: 351357.
  • 6
    Von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, Gammill HS, Powers RW. Plasma levels of inflammatory markers neopterin sialic acid and C-reactive protein in pregnancy and pre-eclampsia. Am J Hypertens 2009; 22: 687692.
  • 7
    Malek A, Bersinger NA, Di Santo S et al. C-reactive protein production in term human placental tissue. Placenta 2006; 27: 619625.
  • 8
    Karinen L, Leinonen M, Bloigu A et al. Maternal serum chlamydia pneumoniae antibodies and CRP levels in women with pre-eclampsia and gestational hypertension. Hypertens Pregnancy 2008; 27: 143158.
  • 9
    Herrera JA, Parra B, Herrera E et al. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. J Hypertens 2007; 25: 14591464.
  • 10
    Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C- reactive protein levels with biochemical and clinical parameters in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 124: 164167.
  • 11
    Mihu D, Costin N, Mihu CM, Blagu LD, Pop RB. C-reactive protein, marker for evaluation of systemic inflammatory response in pre-eclampsia. Rev Med Chir Soc Med Nat Lasi 2008; 112: 10191025.
  • 12
    Abdollahi A, Shoar S. Relationships of serum level of high-sensitivity C-reactive protein (hs- CRP) and white blood cell (WBC) count with gamma glutamyltransferase among Iranian healthy adults. Iran J Pathol 2012; 7: 209214.
  • 13
    Hwang HS, Kwon JK, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 105109.
  • 14
    Meads CA, Cnossen JS, Meher S et al. Methods of prediction and prevention of pre-eclampsia: Systematic review of accuracy and effectiveness literature with economic modeling. Health Technol Assess 2008; 12: iiiiiv. 1–270.
  • 15
    Gagnon A, Wilson RD, Audibert F et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynecol Can 2008; 30: 918929. Review.
  • 16
    Adali E, Kurdoglu M, Adali F, Cim N, Yildizhan R, Kolusari A. The relationship between brachial artery flow-mediated dilatation, high sensitivity C-reactive protein, and uterine artery Doppler velocimetry in women with pre-eclampsia. J Clin Ultrasound 2011; 39: 191197.
  • 17
    Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 121: 154158.
  • 18
    Ertas IE, Kahyaoglu S, Yilmaz B et al. Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester. J Obstet Gynaecol Res 2010; 36: 970977.
  • 19
    Cebesoy FB, Balat O, Dikensoy E, Kalayci H, Ibar Y. CA-125 and CRP are elevated in pre-eclampsia. Hypertens Pregnancy 2009; 28: 201211.
  • 20
    Guven MA, Coskun A, Ertas IE, Aral M, Zoncirci B, Oksuz H. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of pre-eclampsia and fatal birth weight. Hypertens Pregnancy 2009; 28: 190200.
  • 21
    Gammill HS, Powes RW, Cliflon RG et al. Does C-reactive protein predict recurrent pre-eclampsia. Hypertens Pregnancy 2010; 29: 399409.
  • 22
    Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59: 2937.
  • 23
    Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG 2002; 109: 297301.
  • 24
    Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of pre-eclampsia. Am J Hypertens 2004; 17: 154156.
  • 25
    Deveci K, Sogut E, Evliyaoglu O, Duras N. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res 2009; 35: 9498.